{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:12:24Z","timestamp":1757700744555},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1988,12,1]],"date-time":"1988-12-01T00:00:00Z","timestamp":596937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1988,12]]},"DOI":"10.1007\/bf00054205","type":"journal-article","created":{"date-parts":[[2004,10,31]],"date-time":"2004-10-31T07:11:39Z","timestamp":1099206699000},"page":"653-660","source":"Crossref","is-referenced-by-count":24,"title":["OPC-8212 in the treatment of congestive heart failure: Results of a pilot study"],"prefix":"10.1007","volume":"2","author":[{"given":"Spencer H.","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Rector","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Strobeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay N.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/01.CIR.67.5.1065","volume":"67","author":"CS Maskin","year":"1983","unstructured":"Maskin CS, Sinoway L, Chadwick B, et al. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severs congestive heart failure. Circulation 1983;67:1065?1070.","journal-title":"Circulation"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/0002-9149(85)90145-6","volume":"55","author":"SH Kubo","year":"1985","unstructured":"Kubo SH, Cody RJ, Chatterjee K, et al. Acute dose range study of milrinone in conjestive heart failure. Am J Cardiol 1985;55:726?730.","journal-title":"Am J Cardiol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0735-1097(85)80185-6","volume":"6","author":"CA Simonton","year":"1985","unstructured":"Simonton CA, Chaterjee K, Cody RJ, et al. Milrinone in congestive heart failure: Acute and chronic hemodynamic and clinical evaluation. J Am Coll Cardiol 1985;6:453?459.","journal-title":"J Am Coll Cardiol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.CIR.71.5.963","volume":"71","author":"B Massie","year":"1985","unstructured":"Massie B, Bourassa M, Di Bianco R, et al. Long-term oral administration of amrinone for congestive heart failure: Lack of afficacy in a multicenter controlled trial. Circulation 1985;71:963?971.","journal-title":"Circulation"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0002-9149(83)90128-5","volume":"52","author":"CV Leier","year":"1983","unstructured":"Leier CV, Dalpiaz K, Huss P, et al. Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy. Am J Cardiol 1983;52:304?308.","journal-title":"Am J Cardiol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0002-8703(85)90460-0","volume":"110","author":"JR Holmes","year":"1985","unstructured":"Holmes JR, Kubo SH, Cody RJ, Kligfield P. Milrinone in congestive heart failure: Observations on ambulatory ventricular arrhythmias. Am Heart J 1985;110:800?806.","journal-title":"Am Heart J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/0002-9149(87)90918-0","volume":"59","author":"PL Ludmer","year":"1987","unstructured":"Ludmer PL, Baim DS, Antman EM, et al. Effects of milrinene on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987;59:1351?1355.","journal-title":"Am J Cardiol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0002-9149(86)90847-7","volume":"57","author":"RA Goldstein","year":"1986","unstructured":"Goldstein RA, Geraci SA, Gray EL, et al. Electrophysiologic effects of milrinone in patients with congestive heart failure. Am J Cardiol 1986;57:624?628.","journal-title":"Am J Cardiol"},{"issue":"Suppl IV","key":"CR9","first-page":"IV-55","volume":"75","author":"M Packer","year":"1987","unstructured":"Packer M, Leier CV. Survival in congestive heart failure during treatment with drugs with positive inotropic actiona. Circulation 1987;75(Suppl IV):IV-55-IV-63.","journal-title":"Circulation"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02060240","volume":"2","author":"S Sasayama","year":"1986","unstructured":"Sasayama S, Inoue M, Asanoi H, et al. Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure. Heart Vessels 1986;2:23?28.","journal-title":"Heart Vessels"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0735-1097(87)80243-7","volume":"9","author":"H Asanoi","year":"1987","unstructured":"Asanoi H, Sasayama S, Iuchi K, Kameyama T. Acute hemodynamic effects of a new inotropic agent (OPC-8212) in patients with congestive heart failure. J Am Coll Cardiol 1987;9:865?871.","journal-title":"J Am Coll Cardiol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF02128143","volume":"2","author":"M Inoue","year":"1986","unstructured":"Inoue M, Kim BH, Hori M, et al. Oral OPC-8212 for the treatment of congestive heart failure: Hemodynamic improvement and increased exercise capacity. Heart Vessels 1986;2:166?171.","journal-title":"Heart Vessels"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00005650-198108000-00001","volume":"19","author":"M Bergner","year":"1981","unstructured":"Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981;19:787?805.","journal-title":"Med Care"},{"key":"CR14","first-page":"198","volume":"3","author":"TS Rector","year":"1987","unstructured":"Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure: II: Content, reliability and validity of a new measure-The Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987;3:198?209.","journal-title":"Heart Failure"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0003-2697(73)90517-4","volume":"51","author":"PG Passon","year":"1973","unstructured":"Passon PG, Peuler JD. A simplified radiometric assay for norepinephrine and epinephrine. Anal Biochem 1973;51: 613?631.","journal-title":"Anal Biochem"},{"key":"CR16","first-page":"359","volume":"34","author":"G Grupp","year":"1984","unstructured":"Grupp G, Grupp IL, Newman G, Schwartz A. Effects of a new positive inotropic agent, 3,4-dihydro-?-[4-(3,4-demethoxybenzoyl) 1-piperanzinyl]-2(1H)-quinolons (OPC-8212), and its solvent, sulfolane, on isolated heart preparstions of the rat, guinea pigs and dog. Arzneimittel Forschung 1984;34:359?363.","journal-title":"Arzneimittel Forschung"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1253\/jcj.50.37","volume":"50","author":"M Hori","year":"1986","unstructured":"Hori M, Inoue M, Tamai J, et al. Cardiotonic activity of a new inotropic agent, 3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl) 1-piperanzinyl]-2(1H)-quinolinone (OPC-8212), in the dog with and without beta-blocker and CA++ antagonist pretreatment. Jpn Circ J 1986;50:37?44.","journal-title":"Jpn Circ J"},{"key":"CR18","first-page":"347","volume":"34","author":"N Taira","year":"1984","unstructured":"Taira N, Endoh M, Iljima T, et al. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-demethoxybenzoyl) 1-piperanzinyl]-2(1H)-quinolone (OPC-8212), a novel positive inotropic drug, on the dog heart. Arzneimittel Forachung 1984; 34:347?355.","journal-title":"Arzneimittel Forachung"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1254\/jjp.36.379","volume":"36","author":"T Yanagisawa","year":"1984","unstructured":"Yanagisawa T, Endoh M, Taira N. Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle. Jpn J Pharmacol 1984;36:379?388.","journal-title":"Jpn J Pharmacol"},{"issue":"Suppl III","key":"CR20","first-page":"III-117","volume":"73","author":"M Endoh","year":"1986","unstructured":"Endoh M, Yanagisawa T, Taira N, Blinks JR. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Circulation 1986;73(Suppl III):III-117-III-133.","journal-title":"Circulation"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00005344-198603000-00029","volume":"8","author":"G Grupp","year":"1986","unstructured":"Grupp G, Grupp IL, Kojima M, et al. Hemodynamic and electrophysiological effects of a novel positive inotropic drug, OPC-8212, in normal and ?failing? guinea pig heart preparations. J Cardiovasc Pharmacol 1986;8:428?440.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0014-2999(85)90016-0","volume":"117","author":"DA Lathrop","year":"1985","unstructured":"Lathrop DA, Schwartz A. Evidence for possible increase of sodium channel open time and involvement of Na\/Ca exchange by a new positive inotropic drug: OPC-8212. Eur J Pharmacol 1985;117:391?392.","journal-title":"Eur J Pharmacol"},{"key":"CR23","first-page":"657","volume":"240","author":"T Ijima","year":"1987","unstructured":"Ijima T, Taira N. Membrane current changes responsible for the positive inotropic effect of OPC-8212, a new positive inotropic agent, in single ventricular cells of the guinea pig heart. J Pharmacol Exp Ther 1987;240:657?662.","journal-title":"J Pharmacol Exp Ther"},{"key":"CR24","unstructured":"Imoto Y, Yatani A, Schwartz A, Brown AM. Properties of the effects of a new positive inotropie drug, OPC-8212 on single Ca channels (abstr). Circulation 1987;IV-474."},{"key":"CR25","first-page":"188","volume":"3","author":"TS Rector","year":"1987","unstructured":"Rector TS, Francis GS, Cohn JN. Patients' self-assessment of their congestive heart failure: I. Patient perceived dysfunction and its poor correlation with maximal exercise tests. Heart Failure 1987;3:188?191.","journal-title":"Heart Failure"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.CIR.58.3.408","volume":"58","author":"J Morganroth","year":"1978","unstructured":"Morganroth J, Michelson EL, Horowitz LN, et al. Limitations of routine long term electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation 1978; 58:408.","journal-title":"Circulation"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1476-5381.1986.tb16266.x","volume":"88","author":"K Hashimoto","year":"1986","unstructured":"Hashimoto K, Mitsuhashi H. Effects of OPC-8212, a new positive inotropic agent, on canine ventricular arrhythmias, Br J Pharmacol 1986;88:915?921.","journal-title":"Br J Pharmacol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00054205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00054205\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00054205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T23:50:59Z","timestamp":1554249059000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00054205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,12]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1988,12]]}},"alternative-id":["BF00054205"],"URL":"https:\/\/doi.org\/10.1007\/bf00054205","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,12]]}}}